Week In Review: Sanofi Acquires Kadmon, A US-China Pharma, For $1.9 Billion
September 11, 2021 at 14:30 PM EDT
France's Sanofi will acquire Kadmon Holdings of New York City in a $1.9 billion deal. In 2019, Kadmon formed a JV with BioNova Pharma to develop its novel lead drug, Rezurock (belumosudil) in China.
